API CAS 936623-90-4 Sacubitril Valsartan Sodium

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 600/kg
Request Sample
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Experienced Team
The supplier has 12 foreign trading staff(s) and 10 staff(s) with over 6 years of overseas trading experience
In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (12)
  • API CAS 936623-90-4 Sacubitril Valsartan Sodium
  • API CAS 936623-90-4 Sacubitril Valsartan Sodium
  • API CAS 936623-90-4 Sacubitril Valsartan Sodium
  • API CAS 936623-90-4 Sacubitril Valsartan Sodium
  • API CAS 936623-90-4 Sacubitril Valsartan Sodium
  • API CAS 936623-90-4 Sacubitril Valsartan Sodium
Find Similar Products
  • Overview
  • Description
  • COA
  • Application & Funtion
  • Company
Overview

Basic Info.

Model NO.
SENTIAN-Sacubitril Valsartan Sodium
Certification
ISO 9001, FDA
OEM/ODM
Yes
MOQ
50g
Sample
5-10g
Molecular Weight
957.99
Molecular Formula
C24h28nnao5.C24h27n5na2o3.H2O
CAS
936623-90-4
Transport Package
1kg/ Bag, 25kg/Drum
Specification
99%
Trademark
SENTIAN
Origin
China
Production Capacity
50000kg Per Month

Product Description


 

Description

product name Sacubitril Valsartan Sodium
CAS NO. 936623-90-4
Specification 99%
Appearance white powder
Package 1KG/Bag,25Kg/drum
MOQ 1Kg


Sacubitril valsartan sodium tablets are used for adult patients with chronic heart failure with reduced ejection fraction (NYHA class II-IV, LVEF ≤40%) to reduce the risk of cardiovascular death and heart failure hospitalization. In addition, sacubitril valsartan sodium tablets can replace angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor antagonists (ARB) and be used in combination with other heart failure treatment drugs.

It is used for adult patients with chronic heart failure with reduced ejection fraction (NYHA class .LVEF ≤40%) to reduce the risk of cardiovascular death and hospitalization for heart failure.
Sacubitril valsartan sodium tablets can replace angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor antagonists (ARB) and be used in combination with other heart failure treatment drugs.

COA

 

Items Standards Results
Appearance white powder Complies
Specification 99% 99.20%
Loss on Drying ≤ 5.0% Complies
Heavy Metal ≤ 10.0 mg/kg Complies
Pb ≤ 2.0 mg/kg Complies
As ≤ 1.0 mg/kg Complies
Hg ≤ 0.1 mg/kg Complies
Total Plate Count ≤ 1000cfu/g Complies
Yeast&Mold ≤ 100cfu/g Complies
E.coil Negative Negative
Salmonella Negative Negative
Conclusion: in conformity with the enterprise standard

Application & Funtion

Sacubitril-Valsartan Sodium Tablets are a drug used to treat heart failure. Its main effects include improving heart function, reducing the risk of cardiovascular events, and alleviating symptoms.

1. Improve heart function: Sacubitril-Valsartan Sodium Tablets improve the heart's pumping function by inhibiting enkephalinase and increasing the level of natriuretic peptides in the body.

2. Reduce the risk of cardiovascular events: The drug can reduce the heart load and lower blood pressure, which helps reduce the risk of cardiovascular events in patients with heart failure.

3. Alleviate symptoms: For patients with heart failure, Sacubitril-Valsartan Sodium Tablets can relieve symptoms such as dyspnea and edema and improve the quality of life.

4. Protect heart structure: Long-term use can slow down heart remodeling, protect heart structure, and delay the progression of heart failure.

5. Improve exercise tolerance: By improving heart function, Sacubitril-Valsartan Sodium Tablets can improve patients' exercise tolerance, allowing patients to carry out daily activities for a longer period of time.

When using sacubitril/valsartan sodium tablets, patients are advised to follow the doctor's advice and regularly monitor blood pressure and renal function to ensure the safety and effectiveness of the drug. At the same time, patients should pay attention to the adjustment of diet and lifestyle habits to assist drug treatment and achieve better treatment effects.

Company

API CAS 936623-90-4 Sacubitril Valsartan SodiumAPI CAS 936623-90-4 Sacubitril Valsartan SodiumAPI CAS 936623-90-4 Sacubitril Valsartan SodiumAPI CAS 936623-90-4 Sacubitril Valsartan SodiumAPI CAS 936623-90-4 Sacubitril Valsartan SodiumAPI CAS 936623-90-4 Sacubitril Valsartan Sodium

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier